Advertisement
Advertisement
AIM
AIM ImmunoTech Inc.
0.15
USDSponsored
0.00
+1.91%
Nov 06, 15:58 UTC -5
Closed
Pre-Market
0.16
+0.01
+3.23%
AIM ImmunoTech Inc. (AIM) Earnings
AIM Earnings Reports
Positive Surprise Ratio
AIM beat 14 of 32 last estimates.
44%
Next Report
Next Week
Date of Next Report
Nov 16, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/-$0.13
Implied change from Q2 26 (Revenue/ EPS)
-100.00%
/-69.77%
Implied change from Q3 25 (Revenue/ EPS)
-100.00%
/-91.67%
AIM ImmunoTech Inc. earnings per share and revenue
On Aug 07, 2026, AIM reported earnings of -0.43 USD per share (EPS) for Q2 26, missing the estimate of -0.17 USD, resulting in a -150.44% surprise. Revenue reached 26.00 thousand, compared to an expected --, with a 0.00% difference. The market reacted with a -7.85% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.13 USD, with revenue projected to reach -- USD, implying an decrease of -69.77% EPS, and decrease of -100.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Aldeyra Therapeutics, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.06
Surprise
+37.43%
Lipocine Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.36
Actual
-$0.08
Surprise
+77.91%
Ernexa Therapeutics Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$3.91
Actual
-$1.89
Surprise
+51.75%
ZOETIS INC.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.52
Actual
$1.75
Surprise
+14.64%
Dyne Therapeutics, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.92
Actual
-$1.06
Surprise
-15.57%
Amylyx Pharmaceuticals, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.38
Actual
-$0.38
Surprise
+1.04%
Cronos Group Inc. Common Share
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.03
Actual
$0.04
Surprise
+17.65%
Aclaris Therapeutics, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.16
Actual
-$0.12
Surprise
+28.49%
Protara Therapeutics, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.37
Actual
-$0.35
Surprise
+6.17%
Minerva Neurosciences, Inc
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.12
Actual
$1.94
Surprise
+1,629.97%
FAQ
What were AIM ImmunoTech Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, AIM ImmunoTech Inc. reported EPS of -$0.43, missing estimates by -150.44%, and revenue of $26.00K, 0% as expectations.
How did the market react to AIM ImmunoTech Inc.'s Q2 2026 earnings?
The stock price moved down -7.85%, changed from $0.29 before the earnings release to $0.26 the day after.
When is AIM ImmunoTech Inc. expected to report next?
The next earning report is scheduled for Nov 16, 2026.
What are the forecasts for AIM ImmunoTech Inc.'s next earnings report?
Based on 3
analysts, AIM ImmunoTech Inc. is expected to report EPS of -$0.13 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.